ABDX.L Stock Analysis
AB
Uncovered
Abingdon Health PLC is uncovered by Eyestock quantitative analysis.
Rating
To assess the quality of a company's business, we have collected all financial data from the statements and presented them in the form of a single number - the company's rating. Rating value of 100 is the threshold for determining a viable investment.
Low score
Abingdon Health Plc engages in the development, manufacturing, and distribution of diagnostic devices and provide consultancy services to businesses in the diagnostics sector. The company is headquartered in York, North Yorkshire and currently employs 130 full-time employees. The company went IPO on 2020-12-15. The principal activity of the Company includes developing, manufacturing and distributing diagnostic devices and providing consultancy services to businesses in the diagnostics sector. Contract Development, Contract Manufacturing and Product Sales. The Contract Development segment comprises development work for third parties and is recognized over time based on a proportion of completion. The Contract Manufacturing segment comprises contract development and manufacturing activities. The Product Sales segment comprises the sale of ABC-19, pocket diagnostic products, progressive rod cone degeneration (PCRD) tests and antibodies for research use. Its products include COVID-19 Self-Test, Nucleic Acid Detection/Read Out and Plant Health Tests. The company serves various industries, including clinical, animal health, plant health, defense, environment and pharmaceutical.